Analysis of Free-Text Responses in an International Myeloproliferative Neoplasms Patient Survey to Assess Impact of the COVID-19 Pandemic on Clinical Care

Background The COVID-19 pandemic continues to challenge effective treatment delivery to hematologically-compromised patients, including those with myeloproliferative neoplasms (MPNs). MPNs are characterized by clonal proliferation of hematopoietic cell lines in bone marrow. As such, increasing repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Langlais, Blake T., Mead-Harvey, Carolyn, Kosiorek, Heidi E., Mazza, Gina L., Mesa, Ruben, Palmer, Jeanne M., Dueck, Amylou C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
634.Myeloproliferative Syndromes: Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330170/
http://dx.doi.org/10.1182/blood-2020-143172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330170/
http://dx.doi.org/10.1182/blood-2020-143172

Ejemplares similares